Jeffrey Polekoff
Internal Medicine · Marietta, GANPI 1497888192
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.1% of the total across 230 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 16.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,670 and has fallen 98.8% since, to $20 in 2024.
Across 230 payments — averaging $18.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi-aventis U.S. LLC$671
- AstraZeneca$576
- Novo Nordisk$512
- Lilly USA, LLC$416
- AbbVie$349
- Amgen$281
- plus $1K from 17 others
What the payments were for
- Consulting fees$200%
- Speaking & faculty fees$3929%
- Food & beverage$3,75990%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi-aventis U.S. LLC | 19 | $671 |
| AstraZeneca | 35 | $576 |
| Novo Nordisk | 31 | $512 |
| Lilly USA, LLC | 27 | $416 |
| AbbVie(2 entities) | 22 | $349 |
| Amgen | 16 | $281 |
| Merck | 14 | $218 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $210 |
| Amarin Pharma, Inc. | 10 | $180 |
| Astellas Pharma US Inc | 8 | $133 |
| Boehringer Ingelheim | 7 | $108 |
| GSK | 7 | $107 |
| Bristol Myers Squibb | 1 | $101 |
| Kowa Pharmaceuticals America, Inc. | 7 | $99 |
| Eisai Inc. | 5 | $71 |
| Pfizer | 2 | $28 |
| Bayer | 1 | $20 |
| Adlon Therapeutics L.p. | 1 | $19 |
| Johnson & Johnson | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
| Shire North American Group Inc | 1 | $12 |
| Sanofi Pasteur Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SOLIQUA 100/33$300
- RYBELSUS$122
- Otezla$101
How this compares
$4,171 in reported general payments places this provider in the 85th percentile of 3,311 internal medicine providers in Georgia.
Other internal medicine in Marietta
- Ebon BourneMarietta$242K
- Michael GibsonSmyrna$2.2M
- Eduard FatakhovAlpharetta$376K
- Tracey HenryAtlanta$305K
- Sharon TuckettVilla Rica$265K
- Jennifer WoehlerSavannah$207K
- Julian HutchinsGreensboro$201K
- Brian PearlmanDalton$199K
- Scott ParryAtlanta$162K
- Jennifer GilliganAtlanta$162K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.